Breaking News, Promotions & Moves

Cetero Names CEO, Becomes PRACS

Executive appointments follow sale to investors

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cetero Research has named James Carlson, Pharm.D to serve as its chief executive officer. The appointment follows the U.S. District Bankruptcy Court’s approval of the sale of Cetero to its investor group, led by Freeport Financial. The sale was finalized on June 20, 2012, after the company’s period in Chapter 11 bankruptcy. As part of the corporate reorganization, Cetero has been renamed PRACS Institute. Dr. Carlson is a life science industry veteran with more than 30 years of exper...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters